AJCC 7 th FAQ-1. General Rules for Staging. Question:

Similar documents
Major Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging

Registrar s Guide to Chapter 1, AJCC Seventh Edition. Overview. Learning Objectives. Describe intent and purpose of AJCC staging

You Want ME to Stage that Case???

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

3/23/2017. Disclaimer. Common Changes in TNM Staging. Overview. Overview. Understanding Terminology. Overview

Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification

AJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center

Interactive Staging Bee

Completing the Puzzle AJCC TNM Staging Breast. Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017

What s New for 8 th Edition

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.

47. Melanoma of the Skin

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

INTRODUCTION TO CANCER STAGING

AJCC 7 th Edition Staging Disease Site Webinar Colorectum

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by

The Voyage to Direct Coding of AJCC TNM & Stage... Jayne Holubowsky, CTR DelMarVa-DC Educational Meeting Annapolis, MD October 8, 2015.

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Chapter 2 Staging of Breast Cancer

CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Seventh Edition Staging 2017 Melanoma. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Stage: The Language of Cancer

AJCC Cancer Staging 8 th Edition

Seventh Edition Staging 2017 Breast

category cm0. Category will ensure it T1 melanoma. 68 Retinoblastoma

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

The 8th Edition of the TNM Classification for Lung Cancer Background, Innovations and Implications for Clinical Practice

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Outline. How to Use the AJCC Cancer Staging Manual, 7 th ed. 7/9/2015 FCDS ANNUAL CONFERENCE ST PETERSBURG, FLORIDA JULY 30, 2015.

AJCC TNM 6 th Edition Staging Input Data Dictionary

STAGE CATEGORY DEFINITIONS

Minor Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

AJCC 8 th Edition Staging. Minor Rule Changes. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

A Comprehensive Approach to. International Cancer Survival Benchmarking. SurvMark-2

Descriptor Definition Author s notes TNM descriptors Required only if applicable; select all that apply multiple foci of invasive carcinoma

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Introduction & Descriptors

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

When Do I Consider Myself Cured?

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

3/23/2017. Disclosure of Relevant Financial Relationships. Pathologic Staging Updates in Breast Cancer. Pathologic Staging Updates Breast Cancer

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

AJCC CANCER STAGE. Site-Specific Instructions - BREAST. Reference: AJCC Cancer Staging Manual, 7 th Edition

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

8th Edition of the TNM Classification for Lung Cancer. Proposed by the IASLC

14. Mucosal Melanoma of the Head and Neck

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

A schematic of the rectal probe in contact with the prostate is show in this diagram.

MCR MINI UPDATE DECEMBER 2017

Definition of Synoptic Reporting

Gerard M. Doherty, MD

Supporting Information

The Rodger C. Haggitt Memorial Lecture

10. HPV-Mediated (p16+) Oropharyngeal Cancer

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?

The pathology of bladder cancer

Principles of Cancer Staging

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Protocol applies to melanoma of cutaneous surfaces only.

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors

Collaborative Stage Site-Specific Instructions - BREAST

Reporting of Cancer Stage Information by Acute Care Hospitals in Ontario

Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

Oral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi

Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]

Outcomes Report: Accountability Measures and Quality Improvements

Vaginal Cancer Early Detection, Diagnosis, and Staging

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

Gastric Cancer Histopathology Reporting Proforma

A CENTRAL REGISTRY RELIABILITY STUDY

NPCR s TNM Stage Calculator

CONSENSUS ULTRASOUND SURVEILLANCE PROTOCOL AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY FOR MELANOMA

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Physician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters

ACRIN 6666 Therapeutic Surgery Form

In The Abstract. KCR Fall Workshop Goes Regional. Calendar of Events

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

Head & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

AJCC 8 th Edition Staging. Head & Neck Staging. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

[A RESEARCH COORDINATOR S GUIDE]

Transcription:

AJCC 7 th FAQ-1 General Rules for Staging AJCC 7th edition said if in doubt about correct T, N, or M value, use the lower (less advanced) category and if in doubt about stage grouping, choose the lower stage. I wonder if physician only mentioned ct4 (but there may be T4a/T4b of colon cancer), may I report ct4a directly? There is no T4 on p155 in the colon chapter of AJCC 7th edition. There is a possibility the physician is using the 6th edition, where there was a T4. This should be discussed with the physician. The rule about choosing the lower stage is NOT for unknown information being downstaged, but only for where the evidence (physical exam, imaging, etc) is unclear and it is difficult to choose the correct category. The physician couldn't determine it is T4a or T4b from imaging and other exam, so only given ct4 for coding. The rule about choosing the lower stage is suitable in this situation?? Thanks!! If the physician cannot determine, then he should assign the lowest category which is CT4a. There is NO category for T4 in the 7th edition for colon.

AJCC 7 th FAQ-2 Clinical Metastases Staging If a colon patient has a liver meta proven on imaging and physician states cm1, after surgery that biopsy showed the liver meta is negative. Do we need change cm1 to cm0? No, you would not change the clinical staging based on information found after surgical treatment. The clinical stage is what was known at that point in time and is the basis for choosing the treatment. The pathologic stage would include cm0. Then, could you clarify the statement of AJCC 7th Manual about M classification (Table 1.7, page 11). It said Stage a case with a negative biopsy of suspected metastatic site as cm0. Is it only appropriate before surgical treatment? If the negative biopsy is part of the diagnostic workup, then cm0 would be part of the clinical staging. If the negative biopsy took place during the treatment, then it is part of the pathologic staging. AJCC 7 th FAQ-3 Pathologic Stage of Liver A liver cancer patient had the surgery, but the physician did not detect the regional lymph node (pnx). Therefore, we should code the pathologic TNM as pt1-4 Nx M(blank) and stage 999. We wander that if we can use pt cn cm for grouping pathologic stage in this case? If lymph nodes were not removed and examined, the the pn must be pnx. The M should not be blank. The rules in Chapter 1 of the AJCC 7th edition state that the M for the pathologic stage may be either clinical or pathologic. This is most likely cm0. The rules do NOT allow you to use a cn in the pathologic stage. This stage group cannot be assigned unless the N value would not change the stage group, which only applies to Stage IVB. It is important to also record the clinical stage.

AJCC 7 th FAQ-4 Positive Biopsy of Highest Category = Pathologic Staging It isn't clear in Chapter 1 whether the statement 'microscopic confirmation of the highest T/N/M category is sufficient to assign a pathologic stage' means the highest numeric category (for example lung has 3 N categories) or the highest subcategory in the highest category (for example breast has N3a, N3b and N3c subcategories). Please clarify whether the rule/statement includes the highest alphabetic subcategory classifications or just the numeric categories. We have always considered the umbrella category (T2, T4, N3, etc) as sufficient unless the sub-category changes the stage group. For example, in cases where the T4a and T4b are in the same stage group, it would be wrong to not assign ct4a and pt4a just because there wasn't enough information to assign the pt4b when the stage group table only has T4 without the further breakdowns. If the T4a and T4b are in different stage groups, then you must have the ct4b in order to use it to assign the pt4b. The intent is that from a biopsy or other microscopic confirmation you are able to assign the highest T, which lets you assign the highest/worst stage group, knowing that no additional information from a resection could assign a higher stage group. That is how the same information can be used for both the clinical stage T category and the pathologic stage T catgory. The same logic would apply to the highest N category. AJCC Expert Panel Members (consensus with UICC Experts) AJCC 7 th FAQ-5 Coding Clinical /Pathological M Colon cancer patient with multiple metastatic sites (proven by CT/MRI). Physician only performed a biopsy on one metastatic site which was positive. In this case, the clinical M would be coded to M1b but how should the pathological M be coded to M1a or M1b (pathology stage 4a or 4b)? The pathologic M would be M1a, since there is a possibility that the other metastatic site if biopsied is not cancer. But remember that either a pm or a cm may be used when assigning the stage group. Since the cm is a higher category, I would assign pt pn cm and pathologic stage group.

AJCC 7 th FAQ-6 Staging of Esophagus We found that definition of T could be coded for T4 T4A and T4B in the Esophagus chapter of AJCC 7th. However, the grouping table only includes T4A and T4B. If the physician only mentioned T4 in the medical record, should we report T4A directly? And using T4A for staging? Or can we just using T4 for staging? You cannot use T4 for assigning the stage group. It appears in the T category table to help clearly describe the catgory, but the physician must provide the correct T4a or T4b or the case may not be assigned a stage group. To just make all of the T4's a T4a would skew the data, and cannot be done.

AJCC 7 th FAQ-7 Tis of Breast According to AJCC 7th page12, it said CIS is an exception to the stage grouping guildlines, and ptis cn0 cm0 should be reported as both clinical and pathologic stage0. Is that mean, in any situation (even though the doctor staged a breast cancer patient as ct1cn1cm0 stage 1A by imaging), we have to report clinical stage as stage0? No, that statement means that if you have a patient with a ptis cn0 cm0, in the 6th edition rules it was to only be reported as a clinical stage 0, but we now allow that combination to be used for a pathologic stage 0, even though no nodes were removed. So, the other exception about " case with ct and cn and pm1 staged as clinical and pathologic stage group". Is that mean, in any situation (even though the doctor staged a breast cancer patient as ct1cn1cm0 stage 1A by imaging), we have to report clinical stage as stage4? No, you are reading too much into those statements. It just means that IF you have a that situation you can use it for a clinical stage group, whereas in the 6th edition, you could not.